CAS: 917393-39-6 - Lorediplon
Fórmula:C20H15FN4O2S
InChI:InChI=1S/C20H15FN4O2S/c1-12(26)24(2)17-10-13(5-6-15(17)21)16-7-8-22-20-14(11-23-25(16)20)19(27)18-4-3-9-28-18/h3-11H,1-2H3
Clave InChI:InChIKey=NQPOCLFSADOXBR-UHFFFAOYSA-N
SMILES:O=C(C=1SC=CC1)C=2C=NN3C2N=CC=C3C=4C=CC(F)=C(C4)N(C(=O)C)C
- Sinónimos:
- Acetamide, N-[2-fluoro-5-[3-(2-thienylcarbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]-N-methyl-
- Lorediplon
- N-[2-Fluoro-5-[3-(2-thienylcarbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]-N-methylacetamide
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Lorediplon REF: IN-DA00GU8VCAS: 917393-39-6 | 98% | A consultar | Mar 10 Dic 24 |
 | Lorediplon REF: TM-TQ0023CAS: 917393-39-6 | 99.53% | 46,00 €~226,00 € | Mar 17 Dic 24 |
 | Lorediplon REF: TR-L470013CAS: 917393-39-6 | - - - | 10.899,00 € | Mar 21 Ene 25 |
 | Lorediplon REF: 3D-SLB39339CAS: 917393-39-6 | Min. 95% | A consultar | Mar 21 Ene 25 |
Ref: IN-DA00GU8V
| 5mg | 142,00 € | ||
| 10mg | 158,00 € | ||
| 25mg | 293,00 € | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Lorediplon
CAS:917393-39-6
Lorediplon is a novel hypnotic drug acting as a GABAA receptor modulator, differentially active at …
Fórmula:
C20H15FN4O2S
Pureza:
99.53%
Forma y color:
Solid
Peso molecular:
394.42
Ref: TM-TQ0023
| 10mg | 46,00 € | ||
| 25mg | 86,00 € | ||
| 50mg | 149,00 € | ||
| 100mg | 226,00 € | ||
| 1mL*10mM (DMSO) | 51,00 € |
Entrega estimada en Estados Unidos, el Martes 17 de Diciembre de 2024
Lorediplon
Producto controladoCAS:917393-39-6
Fórmula:
C20H15FN4O2S
Forma y color:
Neat
Peso molecular:
394.422
Ref: TR-L470013
| 100mg | 10.899,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
Lorediplon
CAS:917393-39-6
Lorediplon is a novel sedative with a profile that is characterized by a rapid onset …
Fórmula:
C20H15FN4O2S
Pureza:
Min. 95%
Peso molecular:
394.42 g/mol
Ref: 3D-SLB39339
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
